Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)

NCT ID: NCT06767605

Last Updated: 2025-01-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

5000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2016-01-01

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the registry is to know the status of primary biliary colgantis, autoimmune hepatitis, primary sclerosing cholagitis and genetic cholestatic diseases in Spain.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hepatitis Autoimmune Disease Primary Biliary Cholangitis (PBC) Primary Sclerosing Cholangitis (PSC) Cholestatic Genetic Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with a confirmed diagnosis for PBC, HAI, PSC, genetic cholestatic disease

Exclusion Criteria

* Refusal to sign the informed consent for the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Asociación Española para el Estudio del Hígado

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Carlota Londoño Londoño

Role: STUDY_DIRECTOR

Asociación Española para el Estudio del Hígado

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital Clinic

Barcelona, , Spain

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Spain

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Asociación Española para el Estudio del Hígado Asociación Espa

Role: CONTACT

0034915551119

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Maria Carlota Londoño Londoño

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HCB/2016/0565

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Autoimmune Hepatitis Study
NCT00286663 TERMINATED
Liver Cirrhosis Network Cohort Study
NCT05740358 ACTIVE_NOT_RECRUITING